Disease-free survival according to BCL2L13 expression in pediatric ALL. The disease-free survival (DFS) of patients was estimated according to a Kaplan-Meier plot among 190 patients of the COALL/DCOG study cohort. Patients were grouped according to their expression of BCL2L13 (ie, expression higher than (black line) or lower than (gray line) the median).